Top 50 Eversept Partners LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP DEL | 10.33% | 264.3K | $156.7M | +4.62%(+11.68K) | $327.15(+69.92%) | 2026-03-31 | |
| ABVX | ABIVAX SA | 6.86% | 934.4K | $104.0M | +42.05%(+276.59K) | $84.76(+70.65%) | 2026-03-31 | |
| GSK | GSK PLC | 6.49% | 1.79M | $98.5M | -33.38%(-894.55K) | $39.18(+36.97%) | 2026-03-31 | |
| VERA | VERA THERAPEUTICS INC | 5.76% | 2.17M | $87.4M | -29.26%(-899.02K) | $23.47(+75.54%) | 2026-03-31 | |
| NTRA | NATERA INC | 5.07% | 384.7K | $76.9M | +15.01%(+50.22K) | $67.29(+315.11%) | 2026-03-31 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 4.44% | 2.89M | $67.4M | -12.94%(-428.79K) | $13.49(+61.71%) | 2026-03-31 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 3.74% | 1.79M | $56.7M | +24.62%(+353.29K) | $29.18(+31.51%) | 2026-03-31 | |
| PCVX | VAXCYTE INC | 3.54% | 924.2K | $53.7M | -22.84%(-273.53K) | $52.64(+10.92%) | 2026-03-31 | |
| BKD | BROOKDALE SR LIVING INC | 3.22% | 3.57M | $48.8M | +851.79%(+3.19M) | $11.61(+36.69%) | 2026-03-31 | |
| IONS | IONIS PHARMACEUTICALS INC | 3.13% | 632.1K | $47.5M | +17.44%(+93.88K) | $42.88(+90.78%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +18.41% | +66.01% |
| Top 20 Holdings Unweighted | +18.05% | +64.51% |
Sign up free to track Eversept Partners LP, compare funds side by side, and get alerts the moment positions change.